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Abstract
Background Criteria to assess the appropriateness of prescrip-
tions might serve as a helpful guideline during professional
training and in daily practice, with the aim to improve a
patient’s pharmacotherapy.
Objective To create a comprehensive and structured overview
of existing tools to assess inappropriate prescribing.
Method Systematic literature search in Pubmed (1991–2013).
The following properties of the tools were extracted and
mapped in a structured way: approach (explicit, implicit),
development method (consensus technique, expert panel, lit-
erature based), focused patient group, health care setting, and
covered aspects of inappropriate prescribing.
Results The literature search resulted in 46 tools to assess
inappropriate prescribing.Twenty-eight (61%) of 46 tools
were explicit, 8 (17%) were implicit and 10 (22%) used a
mixed approach. Thirty-six (78%) tools named older people
as target patients and 10 (22%) tools did not specify the target
age group. Four (8.5%) tools were designed to detect inap-
propriate prescribing in hospitalised patients, 9 (19.5%) fo-
cused on patients in ambulatory care and 6 (13%) were devel-
oped for use in long-term care. Twenty-seven (59%) tools did
not specify the health care setting. Consensus methods were
applied in the development of 19 tools (41%), the others were
based on either simple expert panels (13; 28%) or on a
literature search (11; 24%). For three tools (7%) the develop-
ment method was not described.
Conclusion This overview reveals the characteristics of 46
assessment tools and can serve as a summary to assist readers
in choosing a tool, either for research purposes or for daily
practice use.
Keywords Drug-related problems . inappropriate
prescribing . assessment tool . drug safety
Introduction
The appropriate prescription of medication should “maximise
efficacy and safety, minimise cost, and respect patient‘s pref-
erences” [1]. Choosing the most appropriate medication for
each patient in order to achieve desired therapeutic outcomes
is a challenge for healthcare professionals in their daily prac-
tice [2]. Criteria to assess the appropriateness of prescriptions
and to improve a patient’s pharmacotherapy might serve as a
helpful guideline during professional training and on the job
on a daily basis. In recent years, with inappropriate prescribing
becoming an important public health concern, different tools
to assess inappropriate prescribing have been developed and
published. These tools showmajor differences in structure and
content. They can be grouped roughly into implicit (judge-
ment-based) and explicit (criterion-based) tools, and tools
showing a combination of both approaches.
Explicit tools are usually developed from published reviews,
expert opinions, and consensus techniques. These criterion-
based tools are mostly drug-oriented and/or disease-oriented
and can be applied with little or no clinical judgement [3].
Explicit criteria are generally used as rigid standards and nei-
ther address individual differences among patients, nor the
complexity and appropriateness of entire medication regimens
[2]. They need to be updated regularly to ensure their conclu-
siveness. Furthermore, each country has specific guidelines,
standards and approved medications, which makes a country-
specific adaption of explicit criteria necessary. The advantages
are the lower cost of application and a higher degree of fairness
in ensuring a more equal care [4].
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Implicit tools are judgement-based, patient-specific, and con-
sider the patient’s entire medication regimen [2]. Implicit criteria
often depend on the user’s knowledge, experience and attitude.
They can also take into account patients’ preferences. However,
they may be time-consuming and can have low reliability [3].
The combination of both explicit and implicit criteria en-
ables to link the advantages of each approach. Explicit guide-
lines serve as background to supply user’s clinical judgement
of patient’s medication and implicit questions provide a patient-
specific approach with mostly a small number of items.
Creating a valid tool for the assessment of the appropriate-
ness of a medication requires adequate evidence. In areas of
health care where higher levels of evidence (e.g. controlled
trials) are missing, consensus techniques are useful methods
to develop an evidence base. These group facilitation tech-
niques were developed to explore the level of consensus among
a group of experts, whereby consensus is reached by summa-
rizing many opinions into a single, agreed-upon, refined opin-
ion [5]. Combining expert opinions with evidence from the
literature seems to be a good approach to create a valid, useful
tool. Types of consensus techniques are the RAND appropri-
ateness method, the Delphi technique and the nominal group
technique (NGT). The RAND combines current scientific ev-
idence with the opinion of elected experts. Panelists rate, meet
for discussion and then re-rate issues of interest. The Delphi
technique consists of multiple questionnaire rounds with feed-
back to the panelists between rounds and uses evidence-based
literature as a basis but omits expert meetings. The NGT is
widely used to generate and prioritize ideas but usually has no
initial review of the current scientific literature [5].
Several publications summarize and compare selected
existing tools to assess the appropriateness of prescribing [2,
6–11], but a comprehensive overview is still missing. The
existing publications either focus on specific patient groups
or only show just a small comparison of the most popular
tools. Therefore, the objective of this study is to provide a
systematic literature search to create a comprehensive and
structured overview of all existing tools. A mapping will
highlight their characteristics and will allow a comparison of
the structure and the content of these tools.
Methods
Pubmed database search included the time period from January
1, 1991, to March 19, 2013. The search strategy contained the
following terms and combinations: Inappropriate Prescribing
[MESH] OR inappropriate prescribing [All Fields] OR inap-
propriate prescribing/classification [All Fields] OR inappropri-
ate prescribing/economics [All Fields] OR inappropriate
prescribing/ethics [All Fields] OR inappropriate prescribing/
history [All Fields] OR inappropriate prescribing/methods
[All Fields] OR inappropriate prescribing/mortality [All Fields]
OR inappropriate prescribing/nursing [All Fields] OR
Fig. 1 Flowchart of the literature
search
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inappropriate prescribing/psychology [All Fields] OR inappro-
priate prescribing/trends [All Fields] OR inappropriate
prescribing/utilization [All Fields] OR inappropriate prescrib-
ings [All Fields] OR inappropriate prescription [All Fields] OR
inappropriate prescriptions [All Fields]. The MESH term “In-
appropriate prescribing” was introduced only in 2011. Prior to
this, “inappropriate prescribing” was included in the broadly
defined MESH term “Drug therapy”. We limited the search to
studies in adults. Articles must have been published in English
or German. The database search was completed with a manual
search from the reference lists of included articles. The review-
er (RT) assessed publications for eligibility by title and abstract
screening. Each article showing uncertainty regarding inclusion
or exclusion criteria was discussed between three of the authors
(RT, CK, ML).
Inclusion and exclusion criteria
We included articles describing tools or computerised decision
support systems to assess inappropriate prescribing, updated
versions of already published tools and adaptations of an
already published tool if its further development was based
on new expert consensus.
We defined the following exclusion criteria: Tools restricted
to specific therapeutic classes (e.g., benzodiazepines, antibi-
otics, etc.), or specific diseases, tools targeted to children,
adaption of already published tools to computerised decision
support systems, medication review techniques which did not
use a tool, educational interventions to improve prescribing
practice, validation studies of previously published tools, and
general guidelines or recommendations to assess inappropriate
prescribing.
Mapping of the tools
We grouped the tools in three main domains (explicit, implicit
and mixed tools). In every domain tools were ordered
according the strength of evidence of their development meth-
od (consensus technique, expert panel, literature based). To
highlight the characteristics of the tools we listed all properties
in a structured way. We categorised inappropriate prescribing
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Fig. 2 Relation between different assessment tools. Tools in boxes repre-
sent criteria, most frequently used as basis for the development of other tools.
(Austrian: Austrian Criteria [33]; Beers: Beers Criteria, different versions
[19–21]; Beers Liste [34]; German Criteria: Unangemessene Arzneistoffe
für geriatrische Patienten [55]; IPET: Improving Prescribing in the Elderly
Tool [53]; KPC: Kaiser Permanente Colorado Criteria [49]; Laroche:
Laroche Criteria [35];Lechevallier : Lechevallier Criteria [50]; Lindblad :
Lindblad’s List of Clinically Important Drug-Disease Interactions [36];
Maio: Maio Criteria [47]; McLeod: McLeod Criteria [22]; NCQA: NCQA
Criteria – High Risk Medications (DAE-A) and potentially harmful Drug-
Disease Interactions (DDE) in the Elderly [37]; New Mexico: New Mexico
Criteria [51]; NORGEP: Norwegian General Practice Criteria [38];
PRISCUS: The PRISCUS List [43]; Rancourt: Rancourt Criteria [39];
Sloane: Sloane List of Inappropriate Prescribed Medicines [54]; Terrell:
Terrell Computerized Decision Support System to reduce potentially inap-
propriate prescribing [26]; Zhan: Zhan Criteria [46])
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Table 1 Explicit tools to assess inappropriate prescribing
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according to Spinewine [3] into underprescribing, over-
prescribing and misprescribing and defined these terms as
follows [12, 13]:
Underprescribing: The omission of a medication that is
needed (no therapy for a given indication)
Overprescribing: The prescription of a medication that is
clinically not indicated (unnecessary therapy)
Misprescribing: The incorrect prescription of an indicated
medication.
We further divided misprescribing in:
– Drug choice: Better alternatives are available (better risk-
benefit ratio or better cost-effectiveness)
– Dosage: Prescribed dose too low or too high or not
correctly adapted to patient characteristics (e.g. renal
function, body weight.)
– Duration of therapy: Duration of therapy too long or too
short
– Duplication: Inappropriate prescription of drugs of the
same pharmacological class
– Drug-Disease, Drug-Drug, Drug-Food Interactions:
Combination of a drug with another drug, with food or
with a medical condition with a potential or manifest
negative impact on the therapeutic outcome
We listed the focused patient group (elderly, all age), and
health care setting (hospital care, ambulatory care, long-term
care). In addition, we added adherence, cost-effectiveness and
whether the tool suggested alternative therapies to the inappro-
priate ones. The aspect of adherence represents, to a certain
extent, the patients’ preferences. Intentional non-adherence
reflects patients’ unwillingness to take their medication, mostly
Table 1 (continued)
●=Aspect totally covered by the criteria. ○=Aspect partially covered by the criteria
Abbreviations:
RDRANDmethod; DpDelphi method; NGTNominal group technique; ExExpert panel; Lit based on literature research; ElElderly; L Patients in long-term care;
HHospitalized patients; AAmbulatory patients; ns not specified
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caused by a therapy regimen which does not respect their
preferences and, according to Barber’s definition [1], is there-
fore inappropriate.
Results
A total of 716 articles was identified through database search.
The numbers of included and excluded articles at each stage
are displayed in a flowchart (see Fig. 1). In the end, 46
publications met the inclusion criteria and described 46 dif-
ferent tools. Twenty (43%) of the 46 tools were related to
previously published tools (see Fig. 2).
Characteristics (see Table 1, 2 and 3)
Twenty-eight (61%) of 46 tools were explicit, 8 (17%) were
implicit and 10 (22%) used a mixed approach. Looking at the
patient groups the tools focused on, thirty-six (78 %) tools
named older people as target patients and 10 (22%) tools did
not specify the target age group. Four (8.5 %) tools were
designed to detect inappropriate prescribing in hospitalised
patients, 9 (19.5%) focused on patients in ambulatory care and
6 (13%) were developed for use in long-term care. Twenty-
seven (59%) tools did not specify the health care setting. Con-
sensus methods were applied in the development of 19 tools
(41%; RAND 2, Delphi technique 16, Nominal group technique
1), the others were based on either simple expert panels (13,
28%) or on a literature search (11, 24%). For three tools (7%) the
development method was not described [14–16].
Aspects of inappropriate prescribing
The aspect of misprescribing was covered to a different extent
by each tool. Fourteen (30%) tools focused on overprescribing,
6 (13%) on underprescribing, 8 (17%) mentioned non-
adherence and 5 (11%) the cost-effectiveness. Fourteen (30%)
tools offered alternative therapies.
Discussion
The rapidly growing number of publications about inappropriate
prescribing demonstrates the increased interest in this topic over
Table 2 Implicit tools to assess inappropriate prescribing
●=Aspect totally covered by the criteria. ○=Aspect partially covered by the criteria
Abbreviations:
RDRANDmethod; DpDelphi method; NGTNominal group technique; Ex Expert panel; Lit based on literature research; El Elderly; L Patients in long-
term care; HHospitalized patients; AAmbulatory patients; ns not specified
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the last decade.Many attempts have beenmade to improve drug
prescribing. Tools to achieve this aim are numerous, as we show
in this overview, each with a different structure and degree of
comprehensiveness and complexity. Many of them might serve
as a useful aid to improve prescribing, but each tool has its
limitations, strengths andweaknesses. In general, an ideal tool to
assess the appropriateness of drug prescriptions should:
& cover all aspects of appropriateness (efficacy, safety, cost-
effectiveness and patients’ preferences)
& be developed using evidence-based methods
& show significant correlation between the degree of inap-
propriateness and clinical outcomes
& be applicable not only in research conditions but also in
daily health care practice
None of the tools we describe in this systematic overview
covers all aspects of inappropriate prescribing. In particular,
underprescribing is only mentioned in 6 tools, although
underprescribing represents an important aspect of inappropriate
prescribing and is prevalent particularly in the elderly [17].
Many tools strongly emphasize the choice of a drug which leads
to a better compliance with treatment guidelines. But respecting
all relevant treatment guidelines without individualisation is in
the best case rational prescribing but not necessarily appropriate
prescribing [18]. Individualisation is therefore a prerequisite for
Table 3 Tools with a mixed approach (explicit/implicit) to assess inappropriate prescribing
●=Aspect totally covered by the criteria. ○=Aspect partially covered by the criteria
Abbreviations:
RDRAND method; DpDelphi method; NGTNominal Group Technique; Ex Expert panel; Lit based on literature research; El Elderly; L Patients in
long-term care; HHospitalized patients; AAmbulatory patients; ns not specified
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appropriate prescribing and, thus, the drug–patient interaction is
implicitly included in any aspect of appropriate prescribing.
The development methods of the tools we mapped varied a
lot and ranged from those which included no information
about any aspects of development, to those which used an
intensive literature search combined with multiple consensus
techniques.
The results obtained from the use of any of the tools
represent process measures. Improving the patient’s prescrip-
tion according to such a tool does not necessarily improve
outcomes (e.g. mortality, morbidity, adverse drug events,
quality of life, etc.). Correlations between process measures
and clinical outcomes should be demonstrated in well-
designed clinical trials. For the majority (39/46) of the tools
we could not find such clinical validation in the literature.
In a systematic review, Spinewine et al. [3] analysed the
correlation between the use of inappropriate medications
according to the Beers Criteria [19–21], the McLeod’s
Criteria [22], and the Medication Appropriateness Index
[23] and patient outcomes: Many studies examined the
Beers Criteria and showed a significant correlation of po-
tentially inappropriate medication (PIM) and negative
clinical outcomes (e.g., mortality, adverse drug reactions,
hospital admission). Additional studies not included in
Spinewine’s review showed evidence that minimizing
inappropriate prescriptions may reduce negative patient
outcomes (see Table 4).
Assessment tools are not intended as a substitute for the
prescriber’s careful clinical decision-making, even if they have
been perfectly validated. Instead, when implemented in daily
practice, they alert health care professionals to the likelihood of
inappropriate prescribing [9]. Such implementation, however,
requires that tools should not only be well designed and com-
prehensive, but also still practical in daily use. Integration of
assessment tools in electronic decision support systems could
be a promising approach [24–27]. One tool, the Barenholtz-
Levy Medication Risk Questionnaire [28] is designed for self-
assessment by the patient which represents a very different
strategy.
A short description of each tool including the number of
items, where assessable (cf. Table 1, 2 and 3), provides some
information about the construction and complexity. The num-
ber of items per tool varies a lot and ranges from less than ten
to more than a hundred items. However a direct relation
between the number of items and the complexity of a tool is
not clearly given. As an example: the implicit Medication
Appropriateness Index (MAI) [23] consists of only 10 ques-
tions to patient’s medication. But the application of the MAI
requires clinical knowledge and is time intensive. On the other
hand the explicit Beers Criteria [29], with a high number of
items, but arranged in a comprehensive way is easy to handle
for a person who is used to it.
Limitations
The literature search was restricted to articles published in
English and German; criteria published in other languages
were reasonably not included because analysing and mapping
the tools required a complete understanding of the text. Liter-
ature search, abstract and full text screening were done by
only one of the authors (RT). Uncertainties were discussed by
all authors. The mapping was developed by one author (RT)
and reviewed by a second (CK). Uncertainties about eligibility
Table 4 Correlation of inappro-
priate prescribing with adverse
patient outcomes
Tool Outcomes References
Beers Criteria - higher probability of hospitalization with 2
or more potentially inappropriate
medications (PIM)
Albert 2010 [73],
Ruggiero 2010 [74],
Passarelli 2005 [75],
Dedhiya 2010 [76],
Gallagher 2008 [42]
- significantly increased risk for ADRs in
elderly with at least one PIM
- increased risk of hospitalisation and
death with PIM
- increased risk of falling when using PIM
Kaiser Permanente Model - lower likelihood of hospitalisation in
high-risk patients when using the Kaiser
Permanent Model of consultation
McCombs 1998 [77]
Lipton Criteria -association between the prescribing
scores and the number of reported
adverse effects
Lipton 1993 [78]
STOPP Criteria - increased risk for ADEs and hospital admission
in patients with PIM
according to STOPP
Hamilton 2011 [79],
Gallagher 2008 [42]
NCQA Criteria - Increased risk of hospitalisation with
medication on the NCQA list
Albert 2010 [73]
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of a study or classification of the tool were discussed by at
least three authors.
Conclusion
Through a systematic literature search we identified 46 different
tools to assess inappropriate prescribing showing a large variety
in methodological aspects and in clinical validation. Not sur-
prisingly with such a variety of tools in such a complex field,
this overview could not identify a single ideal tool but may help
readers to choose one, either for research purposes or for daily
practice use, according to the situation in which it is intended to
be applied. By outlining the characteristics in a highly structured
manner, this overview may reveal strengths and weaknesses,
and thus, may stimulate further research in this area.
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